Subscribe: Market Wire - Medical and Healthcare: Medical Devices
Added By: Feedage Forager Feedage Grade B rated
Language: English
announced  announces  apr  april  company  health  marketwired apr  marketwired april  marketwired  medical  new  results  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Medical Devices

Marketwired - Medical Devices

Marketwired - Medical Devices

Last Build Date: Fri, 28 Apr 2017 11:05:47 EDT

Copyright: Copyright: (C) Marketwired

Titan Medical Ends Negotiations With Longtai Medical for Sport Distribution in Asia Pacific

Fri, 28 Apr 2017 09:58:04 EDT

TORONTO, ON--(Marketwired - April 28, 2017) - Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF) (Titan), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), announces it has terminated its negotiations with Longtai Medical, Inc. (Longtai), a Canadian subsidiary of Ningbo Long Hengtai International Trade Co. Ltd., for distribution of the SPORT single port surgical system in the Asia Pacific region. Titan has determined to focus on execution for initial commercialization in the United States and the European Union, and will return a $2 million deposit to Longtai.

IEC Will Host Conference Call to Discuss Fiscal 2017 Second Quarter Financial Results

Fri, 28 Apr 2017 09:10:03 EDT

NEWARK, NY--(Marketwired - April 28, 2017) - IEC Electronics Corp. (NYSE MKT: IEC) today announced that it will host a conference call on Wednesday, May 10, 2017 at 10:00 a.m. Eastern Time, to discuss its financial results for the fiscal second quarter ended March 31, 2017.

MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations

Fri, 28 Apr 2017 09:01:00 EDT

ORLANDO, FL--(Marketwired - Apr 28, 2017) - MEDITE Cancer Diagnostics, Inc. (OTCQB: MDIT) (the "Company") specializing in the development, manufacturing and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions, announced the restructuring of its organization in Germany to position the Company for revenue growth and profitability.

MTBC to Announce Q1 2017 Financial Results and Host Conference Call on May 10, 2017

Fri, 28 Apr 2017 09:00:00 EDT

SOMERSET, NJ--(Marketwired - Apr 28, 2017) - MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, web-based electronic health records, practice management and mHealth solutions, will release its first quarter financial results for the three months ended March 31, 2017 before the market opens on Wednesday, May 10, 2017. The Company will follow with a conference call for investors on May 10 at 8:30 a.m. EDT to review highlights of its quarterly results and discuss its business outlook and other matters.

Live Webinar on Imaging Diagnostics and Theranostics

Fri, 28 Apr 2017 07:00:00 EDT

Meeting Clinical Development Challenges in the Imaging Diagnostic and Theranostic Space

Zecotek Closes Non-Brokered Private Placement and Provides Update for Divisional Equity Financings

Thu, 27 Apr 2017 23:35:33 EDT

SINGAPORE--(Marketwired - April 27, 2017) -

Rand Capital Announces First Quarter 2017 Results

Thu, 27 Apr 2017 16:39:30 EDT

BUFFALO, NY--(Marketwired - April 27, 2017) -

MEDITE Cancer Diagnostics Appoints Susan Weisman as Chief Financial Officer

Thu, 27 Apr 2017 16:01:00 EDT

ORLANDO, FL--(Marketwired - Apr 27, 2017) - MEDITE Cancer Diagnostics, Inc. (OTCQB: MDIT) (the "Company"), specializing in the development, manufacturing, and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions, today announced the appointment of Susan Weisman as Chief Financial Officer

Align Technology Announces Record First Quarter 2017 Results

Thu, 27 Apr 2017 16:00:00 EDT

SAN JOSE, CA--(Marketwired - April 27, 2017) -

  • Q1 revenues up 5.8% sequentially, up 30.0% year-over-year to a record $310.3 million
  • Q1 Invisalign case shipments up 9.5% sequentially, up 27.1% year-over-year to a record 208 thousand cases
  • Q1 International Invisalign case shipments up 41% year-over-year, North America Invisalign case shipments up 20% year-over-year
  • Q1 Invisalign case shipments to teenage patients up 11.3% sequentially, up 31.6% year-over-year

TEC Edmonton to collaborate on joint incubator with Tsinghua University

Thu, 27 Apr 2017 13:02:15 EDT

EDMONTON, AB--(Marketwired - April 27, 2017) - TEC Edmonton recently signed an agreement with Tsinghua University's research innovation incubator, TusStar. TusStar is the famous brand of Tus Holdings, the investment arm of Tsinghua University. The agreement will enable each organization to better support its high growth incubator clients with their international market development plans.

Significant Milestone Helps ORHub (ORHB) Deliver Cost-cutting Insight to Health Care Providers

Thu, 27 Apr 2017 11:30:14 EDT

Recorded data from 500 surgeries provides hospitals valuable information to improve operating room efficiencies

Savaria annonce la date de divulgation des résultats de son premier trimestre 2017

Thu, 27 Apr 2017 10:21:02 EDT

LAVAL, QUÉBEC--(Marketwired - 27 avril 2017) - Savaria Corporation (« Savaria ») (TSX:SIS), un des chefs de file nord-américain de l'industrie de l'accessibilité, divulguera les résultats financiers de son premier trimestre 2017, le 11 mai prochain après la fermeture des marchés.

Savaria Announces 2017 First Quarter Results Release Date

Thu, 27 Apr 2017 10:20:32 EDT

LAVAL, QUEBEC--(Marketwired - April 27, 2017) - Savaria Corporation ("Savaria") (TSX:SIS), one of North America's leaders in the accessibility industry, will release its 2017 first quarter results after market hours on May 11th, 2017.

VirtualHealth, SUS to Share Successful Results of Improving Care and Reducing Costs of Complex Populations at the 2017 Spring Managed Care Forum

Thu, 27 Apr 2017 10:15:55 EDT

NEW YORK, NY--(Marketwired - Apr 27, 2017) - VirtualHealth, the leading provider of population health and care management technologies, announced today that one of its senior clinicians, Donna Lichti, RN, and Jayresa Sass, Behavioral Intervention Specialist of Services for the UnderServed (SUS), will present at the 2017 Spring Managed Care Forum. The presentation will highlight the extraordinary results SUS, a leading human services agency providing $185 million in services to individuals with disabilities, people living in poverty and those facing homelessness, achieved when it used the VirtualHealth platform to improve patient care and reduce costs associated with its complex populations.

MTBC Announces Signing of Two Key Healthcare Groups

Thu, 27 Apr 2017 09:49:26 EDT

New clients expected to generate more than $1 million in annual revenues

SANUWAVE Announces Cooperation With Ortho-Medico in Europe and Exhibition at EWMA -- Visit Us at Booth Number 3 E14

Thu, 27 Apr 2017 09:00:00 EDT

SUWANEE, GA--(Marketwired - Apr 27, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company will exhibit, in conjunction with Ortho-Medico, at EWMA (European Wound Management Association) in Amsterdam, The Netherlands on 3-5 May 2017. With renewed energy and focus, SANUWAVE is intent on continuing to strengthen our association with doctors, hospitals and wound care centers and re-establishing the Company's products into the EU market.

Aurora Spine Corporation Announces 2016 Year End Results

Thu, 27 Apr 2017 09:00:00 EDT

CARLSBAD, CALIFORNIA--(Marketwired - April 27, 2017) -

Propanc Successfully Completes 28-Day Repeat-Dose Toxicity Study for PRP

Thu, 27 Apr 2017 08:51:47 EDT

Safe Starting Dose for First-In-Human Studies Defined, Clinical Development Stage Commences

The Life Sciences Report Examines How Trial Results Set Up DURECT Corp. for 'Exciting Year'

Thu, 27 Apr 2017 08:45:00 EDT

SAN FRANCISCO, CA--(Marketwired - April 27, 2017) - Positive results in a Phase 1b trial of DURECT Corp.'s (NASDAQ: DRRX) candidate for the treatment of nonalcoholic steatohepatitis (NASH), which were presented at the 2017 International Liver Congress, prompted comments from a pair of analysts.

mCig, Inc. Announces Special Investors Conference Call to Discuss 2017 Outlook

Thu, 27 Apr 2017 08:00:00 EDT

HENDERSON, NV--(Marketwired - Apr 27, 2017) - mCig, Inc., (OTCQB: MCIG) a leading distributor of innovative products, technologies and services for the global medical marijuana industry invites shareholders, prospective investors and interested parties to tune into a special investor's conference call on Monday, May 1, 2017 at 4:30 PM ET.

Respiratory Endpoints, Scientific Leadership and the Asia-Pacific Region, New Webinar Hosted by Xtalks

Thu, 27 Apr 2017 07:30:00 EDT

TORONTO, ON --(Marketwired - April 27, 2017) - In this webinar, Professor Christine Jenkins, Scientific Leader (Respiratory) and Dr. Maria Ali, Associate Director of Medical and Regulatory Services, both from George Clinical, will outline the importance of a coherent endpoint strategy and leveraging scientific leadership early-on in trial design. The live event will take place on Tuesday, May 16, 2017 at 1pm EDT (10am PDT).

Motus GI Holdings, Inc. Announces First U.S. Ambulatory Endoscopy Center Clinical Procedures Using the Pure-Vu(TM) System

Thu, 27 Apr 2017 07:30:00 EDT

NEW HOPE, PA--(Marketwired - April 27, 2017) - Motus GI Holdings, Inc., ("Motus GI" or the "Company"), a medical device company dedicated to improving colonoscopy outcomes and experiences, today announced that it has completed its first series of clinical procedures using the Pure-VuT system in a U.S. ambulatory endoscopy center ("AEC") by Gerald Bertiger, MD, Gastroenterologist, at Hillmont GI, in Flourtown, PA. Dr. Bertiger's first clinical use was on March 27th, 2017 in a patient who previously failed multiple colonoscopies due to an inadequate prep, however, with the use of the Pure-Vu system was able to perform a successful colonoscopy. Dr. Bertiger and his colleagues have since performed additional colonoscopy procedures using Pure-Vu system.

Sirrus Corp. Provides Overview of its Penetration Testing Services

Thu, 27 Apr 2017 07:00:00 EDT

JOHNS CREEK, GA--(Marketwired - Apr 27, 2017) - Sirrus Corp. ("Sirrus" or the "Company") (OTC PINK: SRUP), an emerging cybersecurity solutions provider, today provides this overview of its main line of business, Penetration Testing Services.

First Ten MUSE(TM) Procedures for GERD Performed in China as Part of CFDA Multi-Center Clinical Study

Thu, 27 Apr 2017 07:00:00 EDT

OMER, ISRAEL--(Marketwired - Apr 27, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced that the first ten procedures have been performed as the initial phase of the China Food and Drug Administration, or CFDA, multi-center MUSET Clinical Study in China.

Konica Minolta Supports Breast Tomosynthesis Education at 2017 SBI/ACR Pre-Conference DBT Workshop with Exa(TM) Mammo

Wed, 26 Apr 2017 15:16:21 EDT

WAYNE, NJ--(Marketwired - April 26, 2017) - Konica Minolta Healthcare Americas, Inc. displayed its commitment to Digital Breast Tomosynthesis (DBT) education as a sponsor of this year's Pre-Conference DBT Workshop at the 2017 SBI/ACR Breast Imaging Symposium from April 6-9 in Los Angeles, CA. The workshop provided eight hours of initial training in DBT as required by the FDA and attendees had the opportunity to review and report cases on individual DBT workstations, such as Konica Minolta's ExaT Mammo.

NSAV Medical Cannabis Company Announces Launch of New Corporate Website

Wed, 26 Apr 2017 15:12:42 EDT

CRESCO, PA--(Marketwired - Apr 26, 2017) -  Net Savings Link, Inc. (OTC: NSAV) announced today that the Company has officially launched its new corporate website, which is now available at

TEC Edmonton announces finalists for 15th VenturePrize awards

Wed, 26 Apr 2017 11:00:00 EDT

EDMONTON, AB--(Marketwired - April 26, 2017) - For the 15th year, Alberta-based technology companies will compete for top prizes with a combined value of over $150,000 at the VenturePrize awards celebration on May 4, 2017. TEC Edmonton announced Tuesday the finalists for the Fast Growth, DynaLIFE Health, and TELUS ICT competition streams, which include some of the most promising companies from Alberta with a technology-based venture.

Streetwise Reports Examines How AudioEye Is Making the Internet Accessible to All

Wed, 26 Apr 2017 10:27:35 EDT

SAN FRANCISCO, CA--(Marketwired - April 26, 2017) - AudioEye Inc.'s (OTCQB: AEYE) innovative technology, which makes the internet available to people with disabilities, has led to rapid growth for the company.

DirectTrust Continues Steady Growth in Number of Direct Exchange Users, Addresses and Transactions during First Quarter

Wed, 26 Apr 2017 09:15:00 EDT

Six new members join DirectTrust since January 1

Titan Medical Issued U.S. Patent Related to SPORT Surgical System Robotic Instruments

Wed, 26 Apr 2017 09:03:12 EDT

TORONTO, ON--(Marketwired - April 26, 2017) - Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), announces the issuance of U.S. Patent No. 9,629,688 titled "Actuator and Drive for Manipulating a Tool," which covers the Company's unique robotic surgical instruments and in particular the novel interface and drive mechanism.

New AbleGamers Center for Inclusive Play Dramatically Expands Charity's Ability to Support Nation's 33 Million Gamers With Disabilities

Wed, 26 Apr 2017 09:00:00 EDT

Digital Accessibility Firm SSB BART Group Provides Generous Grant, Enabling the AbleGamers Foundation to Offer Enhanced Disability Educational Resources and Direct Support

The Sequoia Project Celebrates Five Years with Significant Growth in Enabling Seamless, Nationwide Health Data Exchange

Wed, 26 Apr 2017 08:57:29 EDT

Growth Marked by Increases in Participation, Number of Health Records Exchanged and Connectivity Expansion in All 50 States

Market Access Strategy & Payer Relationships Dominate Average Budget Allocation Among Top 10 & Top 50 Pharma Companies

Wed, 26 Apr 2017 08:30:00 EDT

Top 10 market access teams spend approximately $6.7 million on average for market access strategy and payer relationships, Top 50 firms expend less

Spectral Expands Distribution of EAA(TM) In the Middle and Far East and in Europe

Wed, 26 Apr 2017 08:00:00 EDT

TORONTO, ONTARIO--(Marketwired - April 26, 2017) - Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced the renewal and expansion of its exclusive distribution agreements with Toray Medical Co., Ltd. (TMC) and ESTOR SpA (ESTOR) for Spectral's rapid test for the assessment of endotoxin activity in human whole blood (EAAT). The diagnostic will be sold primarily in conjunction with the ToraymyxinT (PMX) hemoperfusion cartridge, which removes endotoxin from the bloodstream and is currently approved for use in many countries outside of the United States.

Translational Platforms to Model Pre-Diabetes, Diabetes, and Diabetic Complications, New Webinar Hosted by Xtalks

Wed, 26 Apr 2017 07:30:00 EDT

A key challenge in preclinical studies of diabetes is the lack of translational platforms that can model the various aspects of disease progression and associated complications.

Quantitative Immunohistochemistry for Development of Predictive Biomarkers in Oncology Clinical Trials, New Webinar Hosted by Xtalks

Wed, 26 Apr 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - April 26, 2017) - In a special presentation, industry expert Dr. Belma Dogdas, Associate Principal Scientist from Merck, Inc. will discuss how in oncology studies, biomarkers have been effectively used to measure tumor progression and to evaluate efficacy of therapies. Increasingly they have been utilized to stratify different patient groups and to develop personalized therapeutic strategies. Towards this goal, immunohistochemistry (IHC) has been playing an increasing role to help understand the mechanism of action by measuring molecular targets for cancer types. Through quantitative analysis of IHC images, effective biomarkers can be predictors of disease prognosis and immune response of various immunotherapies.

SuperSonic Imagine's Aixplorer(R) Ultrasound System Delivers Enhanced Liver Imaging to SurgOne, P.C.

Wed, 26 Apr 2017 05:00:00 EDT

Patients at this Denver facility now receive non-invasive 60-second liver assessment

Zecotek Announces Non-Brokered Private Placement

Tue, 25 Apr 2017 19:44:56 EDT

SINGAPORE--(Marketwired - April 25, 2017) -

Model N Kicks Off Rainmaker 2017, The Premier Revenue Management Conference

Tue, 25 Apr 2017 18:10:00 EDT

Former Vermont Gov. Howard Dean, former Oklahoma Sen. Tom Coburn and industry experts discuss key trends and strategies for Revenue Management as a Service (RMaaS)

MedX Health Corp. Announces Closing of Brokered Private Placement

Tue, 25 Apr 2017 17:50:06 EDT

MISSISSAUGA, ON--(Marketwired - April 25, 2017) -


Oticon Opn(TM) Brings Home the Gold at the 2017 Edison Awards

Tue, 25 Apr 2017 14:57:21 EDT

And Adds 2017 Red Dot Award to Opn's Growing List of International Awards

ProSolus Seeks Higher Utilization of Transdermal Drug Delivery Technology

Tue, 25 Apr 2017 14:38:23 EDT

Parent company, Mission Pharmacal, expands commitment to patch technology with significant investments in manufacturing and commercial team

MTBC Announces Partnership with Healthcare Compliance Network

Tue, 25 Apr 2017 13:16:59 EDT

SOMERSET, NJ--(Marketwired - Apr 25, 2017) - MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of mHealth and cloud-based clinical and practice management solutions, today announced its new partnership with Health Compliance Network, LLC, a leading provider of compliance solutions to hospitals and medical groups throughout the United States.

Professional Basketball Players Can Now Use Light Therapy Technology to Improve Muscle Recovery, Joint Motion & Post-exercise Soreness at IASIS Healthcare's Multi Specialty Clinic in Phoenix

Tue, 25 Apr 2017 12:59:52 EDT

PHOENIX, AZ--(Marketwired - Apr 25, 2017) - CryoUSA, a leader in providing whole body cryotherapy and other recovery modalities, announced today that the Phoenix Suns and Phoenix Mercury are the first NBA and WNBA professional sports franchises to purchase a NovoTHOR Whole Body Light Pod, which is installed at IASIS Healthcare's Multi Specialty Clinic in downtown Phoenix.

Expectant moms hope Kathleen Wynne will deliver on child care promises

Tue, 25 Apr 2017 12:34:22 EDT

What to expect when you're expecting child care in the provincial budget

YO(TM) Home Sperm Test Participates in National Infertility Awareness Week

Tue, 25 Apr 2017 11:07:02 EDT

The first FDA cleared Smartphone based technology for male fertility testing is encouraging men to dive in and test their swimmers

Fovia and Predible Health Combine XStream(R) HDVR(R) with Deep Learning to Fight Cancer

Tue, 25 Apr 2017 09:00:00 EDT

Alliance Overcomes Major Obstacle in Deployment of AI

Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2017

Tue, 25 Apr 2017 09:00:00 EDT

SALT LAKE CITY, UT--(Marketwired - Apr 25, 2017) - In the first calendar quarter (1Q) of 2017, Utah Medical Products, Inc. (NASDAQ: UTMD) achieved results representing a strong start to achieving its financial goals for year 2017.

Ivantis Announces FDA Clearance to Initiate Clinical Trial of the Hydrus(TM) Microstent for Minimally Invasive Glaucoma Surgery (MIGS) in Patients with Advanced Glaucoma

Tue, 25 Apr 2017 08:05:00 EDT

IRVINE, CA--(Marketwired - Apr 25, 2017) - Ivantis Inc., developer of the novel HydrusT Microstent device, designed to lower eye pressure for glaucoma patients, announced today that the US Food and Drug Administration (FDA) has granted the company clearance to initiate a second investigational device exemption (IDE) clinical trial of the Hydrus Microstent. This trial will involve patients with advanced glaucoma, undergoing stand-alone glaucoma surgery without combined cataract surgery.

InCrowd Captures Market Momentum with Three New Hires

Tue, 25 Apr 2017 08:00:00 EDT

With Its New Automated Solutions for Qualitative Research, Tracking Studies Driving Strong Q1 2017 Results, InCrowd's New Leaders Will Help Accelerate Company's Growth

DiaMedica Announces Dr. Nancy Chang to its Strategic Advisory Board

Tue, 25 Apr 2017 08:00:00 EDT

MINNEAPOLIS, MINNESOTA--(Marketwired - April 25, 2017) - DiaMedica Therapeutics Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) is pleased to announce the addition of Dr. Nancy Chang to its Strategic Advisory Board to support the Company's development of its lead product, DM199. Dr. Chang brings more than 30 years of experience in the biopharmaceutical industry, successfully developing and commercializing therapeutic and diagnostic products. She is the co-founder of Tanox, Inc., a biotechnology company known for the development of Xolairâ, the breakthrough drug which changed the treatment model for allergy-induced asthma. Dr. Chang served as President and CEO of Tanox until its acquisition in 2007 by Genentech for US$919 million.

Half of Pharma Global Teams' Pharmacovigilance Funding is Contributed by a Standalone Drug Safety Team

Tue, 25 Apr 2017 07:30:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwired - April 25, 2017) - On average, half (50%) of surveyed global teams' pharmacovigilance funding is contributed by a standalone drug safety team, according to data published by industry intelligence provider Cutting Edge Information.

Upcoming Webinar to Examine Implementing Basket/Bucket and Umbrella Designs: What You Need to Know for Global Oncology Trials

Tue, 25 Apr 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - April 25, 2017) - On Monday, May 8, 2017, Xtalks will host a complimentary webinar with a panel of speakers from Covance, featuring: Amy Franke, Senior Director of Strategy and Planning, Bridget (Fitzsimmons) Weeks, Director of Project Management (Oncology) and Montessa Lizaso, Senior Data Analyst for Strategy and Planning (Oncology).

Outcomes-Based Agreements and Innovative Contracting for Biopharmaceuticals: Where Is The Market Moving?, New Webinar Hosted by Xtalks

Tue, 25 Apr 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - April 25, 2017) - During a live broadcast on Wednesday, May 10, 2017, industry expert Janice Watch, Divisional Principal, Head of EU Pricing and Market Access from ICON Commercialisation and Outcomes will provide a deeper understanding of the changing contracting landscape and to learn ways to leverage new and innovative approaches to improve the commercial success of your biopharmaceutical products.

biOasis Appoints Mark Day, Ph.D., as Chief Executive Officer and Director

Mon, 24 Apr 2017 17:07:00 EDT

VANCOUVER, BC--(Marketwired - April 24, 2017) -

Cocrystal Pharma Receives Investment Through Private Placement

Mon, 24 Apr 2017 16:15:00 EDT

BOTHELL, WA and ATLANTA, GA--(Marketwired - Apr 24, 2017) - On April 20, 2017, Cocrystal Pharma, Inc. (OTCQB: COCP) (the "Company") closed on proceeds of $3,000,000 in a private placement offering (the "Offering") of 12,500,000 shares of the Company's common stock at a purchase price of $0.24 per share. The purchasers included one of the members of the Company's board of directors, Chairman Dr. Raymond F. Schinazi. In addition, OPKO Health, Inc. invested in the Offering, of which the Company's director Dr. Phillip Frost is Chairman and Chief Executive Officer.

Quidel Reports First Quarter 2017 Financial Results

Mon, 24 Apr 2017 16:10:00 EDT

SAN DIEGO, CA--(Marketwired - April 24, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the first quarter ended March 31, 2017.

OntarioMD appoints new skills-based Board of Directors to guide strategic direction

Mon, 24 Apr 2017 15:20:00 EDT

TORONTO, ON--(Marketwired - April 24, 2017) - OntarioMD is pleased to announce that it has concluded its search for a new Board of Directors to guide the company to achieve its vision and mission to expand the adoption and enhanced use of digital health solutions for community-based physicians and to further support its new strategic direction.

Proxy Biomedical Group Announces New Corporate Brand Aran Biomedical

Mon, 24 Apr 2017 12:00:00 EDT

Aran Biomedical to provide outsourced design, development and manufacturing of implantable medical devices for Cardiovascular, General Surgery and Orthopaedics markets

Titan Medical to Present at Bloom Burton & Co. Healthcare Investor Conference 2017

Mon, 24 Apr 2017 09:41:10 EDT

TORONTO, ON--(Marketwired - April 24, 2017) - Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), today announced that David McNally, President and CEO of Titan Medical, will present at Bloom Burton & Co. Healthcare Investor Conference on Monday, May 1 at 10:30 a.m. Eastern time. Mr. McNally will provide a corporate overview discussing the Company's SPORT Surgical System, currently under development. The conference is taking place at the Sheraton Centre Toronto Hotel in Toronto, Canada on May 1st and 2nd.

Bellatora, Inc. Partners with Award Winning Agronomist, Enters Multi-Billion Dollar Medical Marijuana Vaping Sector

Mon, 24 Apr 2017 09:00:00 EDT

ANAHEIM, CA--(Marketwired - Apr 24, 2017) - Bellatora Inc. (OTC: ECGR) is a U.S.-based manufacturer, marketer, and distributor of innovative vaporizer products and eLiquids for alternative tobacco and marijuana consumption. 

eWellness Executes PHZIO Beta User Agreement with Jackson Clinics

Mon, 24 Apr 2017 09:00:00 EDT

CULVER CITY, CA--(Marketwired - Apr 24, 2017) - eWellness Healthcare Corporation (OTCQB: EWLL), a provider of the state of the art PHZIO Platform for the physical therapy and telehealth markets, announced today that it has executed a 90-day PHZIO beta user agreement with Jackson Clinics, LP, which has 15 clinics located in Northern Virginia,

Artec 3D Releases Artec Studio 12 Software Featuring Enhanced 3D Intelligence, Speed and Workflow

Mon, 24 Apr 2017 09:00:00 EDT

New Intelligence-Based Software Saves Post-Processing Time with 28 New Features for New and Experienced Users

Advantis Corp. Co-Brands, Launches Natural Elements Tea

Mon, 24 Apr 2017 08:30:00 EDT

NEWPORT BEACH, CA--(Marketwired - Apr 24, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) is launching the co-branded line of Natural Elements Teas this week.

SpeeDx and Thermo Fisher Scientific Announce Strategic Partnership for FDA Clearance of Molecular Diagnostic

Mon, 24 Apr 2017 08:00:00 EDT

ResistancePlus(TM) MG Test would bring disease and antibiotic resistance testing to U.S. market for sexually transmitted infection and potential "superbug"

Yorktel Unveils Latest FeatherMed Portable Telehealth Kit at ATA 2017

Mon, 24 Apr 2017 08:00:00 EDT

New modular design compatible with most video platforms provides customization, flexibility and interoperability; optimizes bringing remote clinicians to the bedside, wherever the patient is

Nephros Announces Partnership with WorldWater & Solar Technologies

Mon, 24 Apr 2017 07:31:02 EDT

RIVER EDGE, NJ--(Marketwired - Apr 24, 2017) -  Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, and WorldWater & Solar Technologies, Inc., a leader in integrated solar platform technology that uses sunshine to drive motors and pumps in large-scale irrigation and municipal water delivery systems, jointly announced today that they have signed a partnership agreement to incorporate Nephros ultrafilters into their solar powered drinking water systems.

Upcoming Webinar to Optimise Your Medical Publications and Avoid "Predatory Journals"

Mon, 24 Apr 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - April 24, 2017) - On Tuesday, May 9, 2017, join a panel of industry experts to learn tips and tools to enhance your medical publication efforts and avoid so-called "predatory journals". Jeffrey Beall, Scholarly Communications Librarian and Associate Professor at the University of Colorado Denver, and ICON's PubsHub team will discuss the growth of open access publishing and what precautions you can take to avoid falling into costly and career damaging traps. Learn best practices and tools to:

Turning Biorepositories into Translational Science Treasure Troves, New Webinar Hosted by Xtalks

Mon, 24 Apr 2017 07:00:00 EDT

The Value of Uniquely Complete Data Sets, Put All Your Specimens -- and All of Their Data -- At Your Fingertips System

Akers Biosciences Updates on Akers Wellness(TM) Tests

Mon, 24 Apr 2017 07:00:00 EDT

Akers Wellness iOS digital application approved by the Apple App Store

Amedica Announces Regulatory Clearance to Market and Sell Valeo(R) Silicon Nitride Spinal Implants in Australia

Mon, 24 Apr 2017 07:00:00 EDT

Australian Marketing Clearance Provides Opportunities for Global Expansion

ClearCorrect announces new Flex and Unlimited pricing

Sat, 22 Apr 2017 12:00:00 EDT

ROUND ROCK, TX--(Marketwired - April 22, 2017) - ClearCorrect, LLC, a leading manufacturer of clear aligners, announced their new customizable FlexT and full-featured UnlimitedT pricing options at the AAO 2017 Annual Session. For the first time, doctors will be able to choose between paying per aligner or one flat rate for five years of unlimited aligners and retainers.

Starkey Hearing Technologies' Halo 2 Wins Silver Edison Award in "Hearing Technology"

Fri, 21 Apr 2017 17:42:24 EDT

Innovative Made for iPhone(R) hearing technology honored for positive user benefits

Reliq Health Technologies Corporate Update

Fri, 21 Apr 2017 16:46:56 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 21, 2017) - Reliq Health Technologies Inc. (TSX VENTURE:RHT)(OTCQB:RQHTF) ("Reliq" or the "Company"), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that further to the Company's news releases dated March 29, 2017 and April 20, 2017 the Company has received TSX Venture Exchange (the "Exchange") final approval and closed the convertible debenture financing (the "Financing") for gross proceeds of $762,304.97.